Undesirable drug interactions. Notes on general principles
Reinicke, C.; Wessel, G.
Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 34(18): 504-505
1979
ISSN/ISBN: 0044-2542 PMID: 516835 Document Number: 144556
Increasing knowledge about undersirable drug interactions make necessary new differential-therapeutic considerations. It is attempted to meet the problem in its general importance and - without any over-refinements which have nothing to do with practice - to draw conclusions for pharmacotherapy.
Document emailed within 1 workday
Related Documents
Dworacka, M.; Nowocień, T. 2017: Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 42(248): 61-64Filipczyk-Cisarz, E. 2000: Clinical implications of undesirable consequences of antineoplastic drug interactions Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 9(51): 632-633
Klimova, E.A.; Timina, V.P. 1986: Probability of occurrence of undesirable effects of drug interactions in the treatment of suppurative meningitis Sovetskaia Meditsina 12: 119-121
Helmchen, H.; Hippius, H.; Rosenberg, L. 1971: Double-blind study of 3 antidepressive drugs. 1. General notes on methods and evaluation principles, with special consideration of the dropout problem Arzneimittel-Forschung 21(5): 629-635
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Nordbo, K. 1975: Drug interactions and general practitioners Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(6): 386
Manzardo, S.; Falcone, A.; Pinzetta, A.; Ieva, G.; Coppi, G. 1994: General pharmacology of pidotimod and testing for drug interactions Arzneimittel-Forschung 44(12a): 1441-1447
Fürtig, W.; Heydel, E.; Box, A. 1984: Pharmacokinetic mechanisms of drug interactions. 1. General problems Die Pharmazie 39(1): 71-73
Tanasijević, G.; Gagić, B.; Jovanović, D.; Arandjelović-Jaćimović, I.; Stojković-Gavrilović, G. 1998: Recognition of cardiovascular drug interactions in general medical practice Vojnosanitetski Pregled 55(6): 623-625
García Morillas, M.; Caracuel Ruiz, M.D.; Sánchez de la Cuesta, F. 1988: Interactions and undesirable side effects of platelet aggregation inhibitors Medicina Clinica 90(13): 553-555
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Bressler, R. 2005: Herb-drug interactions: interactions between ginseng and prescription medications Geriatrics 60(8): 16-17
Lechat, P. 1974: Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance La Nouvelle Presse Medicale 3(24): 1571-1573
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686
Hensjö, L.O. 1995: A new classification introduced in Fass (Swedish Drug Index). a simple way for assessment of drug interactions Lakartidningen 92(38): 3479-3480
Wagner, J.G.; Weidler, D.J.; Lin, Y.J. 1976: New method for detecting and quantitating pharmacokinetic drug-drug interactions applied to ethanol-propranolol Research Communications in Chemical Pathology and Pharmacology 13(1): 9-18